{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_001130805.3:c.5743A>T",
          "cDNA Change": {
            "transcript": "NM_001130805.3",
            "ref": "A",
            "alt": "T",
            "position": "5743"
          },
          "Protein Change": {
            "ref": "I",
            "alt": "T",
            "position": "1915"
          },
          "Description in input context": "I1915T mutation in Drosophila LRRK2"
        },
        {
          "HGVS": "NM_001130805.3:c.6056G>A",
          "cDNA Change": {
            "transcript": "NM_001130805.3",
            "ref": "G",
            "alt": "A",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "A",
            "position": "2019"
          },
          "Description in input context": "G2019S mutation in human LRRK2"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005301"
  },
  "Experiment Method": [
    {
      "Assay Method": "EGFP reporter assay",
      "Material used": {
        "Material Source": "Transgenic model",
        "Material Name": "Drosophila and human cells",
        "Description": "EGFP reporter with let-7-binding sites was used to assess miRNA activity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130805.3:c.5743A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function (increased EGFP expression)",
          "Result Description": "Pathogenic variants (I1915T and G2019S) caused increased EGFP expression compared to wild-type."
        },
        {
          "Variant": "NM_001130805.3:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function (increased EGFP expression)",
          "Result Description": "Pathogenic variants (I1915T and G2019S) caused increased EGFP expression compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or wild-type miRNA was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "EGFP expression levels consistent with wild-type controls.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "EGFP expression levels exceeding wild-type by more than 20%.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "RNAi and gene knockdown",
      "Material used": {
        "Material Source": "Cell culture",
        "Material Name": "Drosophila S2 cells",
        "Description": "RNAi was used to knock down LRRK2 expression to study functional effects."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001130805.3:c.5743A>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function (reduced LRRK2 expression)",
          "Result Description": "RNAi targeting LRRK2 reduced protein levels, confirming functional impact of the mutation."
        },
        {
          "Variant": "NM_001130805.3:c.6056G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Loss-of-function (reduced LRRK2 expression)",
          "Result Description": "RNAi targeting LRRK2 reduced protein levels, confirming functional impact of the mutation."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector or non-targeting siRNA was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "LRRK2 protein expression levels within 10% of wild-type.",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "LRRK2 protein expression levels below 50% of wild-type.",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}